Use of hippocamal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people

被引:175
作者
den Heijer, T
Geerlings, MI
Hoebeek, FE
Hofman, A
Koudstaal, PJ
Breteler, MMB
机构
[1] Erasmus Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Med Ctr, Dept Neurol, NL-3000 DR Rotterdam, Netherlands
[3] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
关键词
D O I
10.1001/archpsyc.63.1.57
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Context: The recent focus on the development of preventive interventions for Alzheimer disease has fueled the search for biomarkers of presymptomatic disease. Patients with Alzheimer disease and mild cognitive impairment have marked atrophy of the hippocampus and amygdala compared with healthy elderly people. Whether atrophy of these structures is also present in persons without cognitive impairment who later develop dementia is unknown. Objective: To assess whether volumetric assessment of the hippocampus and amygdala using magnetic resonance imaging (MRI) predicts dementia in elderly people without cognitive impairment. Design: Longitudinal cohort study. Setting: A general community in the Netherlands. Participants: Five hundred eleven persons, aged 60 to 90 years, free of dementia at baseline were followed up during 3043 person-years (mean per person, 6.0 years). We performed volumetric assessment of the hippocampus and amygdala, obtained information about daily memory problems, and performed extensive neuropsychological testing in all study participants. Main Outcome Measure: Dementia, as assessed by repeated neuropsychological screening and monitoring of medical records. Results: Thirty-five persons developed dementia (26 with Alzheimer disease). Hippocampal and amygdalar volumes were strongly associated with the risk of dementia; the age-, sex-, and education-adjusted hazard ratio per 1-SD decrease in volume was 3.0 (95% confidence interval, 2.0-4.6) for the hippocampus and 2.1 (95% confidence interval, 1.5-2.9) for the amygdala. The hazard ratios associated with atrophy were similar in persons without memory complaints or low cognitive function at baseline. Compared with those remaining free of dementia, baseline brain volumes were 17% smaller in persons who received a clinical diagnosis of dementia within 2 to 3 years after MRI and still 5% smaller in those whose conditions were diagnosed 6 years after MRI. Conclusion: Atrophy of the hippocampus and amygdala on MRI in cognitively intact elderly people predicts dementia during a 6-year follow-up.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 33 条
[21]   MRI measures of entorhinal cortex vs hippocampus in preclinical AD [J].
Killiany, RJ ;
Hyman, BT ;
Gomez-Isla, T ;
Moss, MB ;
Kikinis, R ;
Jolesz, F ;
Tanzi, R ;
Jones, K ;
Albert, MS .
NEUROLOGY, 2002, 58 (08) :1188-1196
[22]   Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls) [J].
Krasuski, JS ;
Alexander, GE ;
Horwitz, B ;
Daly, EM ;
Murphy, DGM ;
Rapoport, SI ;
Schapiro, MB .
BIOLOGICAL PSYCHIATRY, 1998, 43 (01) :60-68
[23]   Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study [J].
Laakso, MP ;
Partanen, K ;
Riekkinen, P ;
Lehtovirta, M ;
Helkala, EL ;
Hallikainen, M ;
Hanninen, T ;
Vainio, P ;
Soininen, H .
NEUROLOGY, 1996, 46 (03) :678-681
[24]   Hippocampus in Alzheimer's disease: A 3-year follow-up MRI study [J].
Laakso, MP ;
Lehtovirta, M ;
Partanen, K ;
Riekkinen, PJ ;
Soininen, H .
BIOLOGICAL PSYCHIATRY, 2000, 47 (06) :557-561
[25]  
LEHERICY S, 1994, AM J NEURORADIOL, V15, P929
[26]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[27]   Incidence of AD may decline in the early 90s for men, later for women - The Cache County study [J].
Miech, RA ;
Breitner, JCS ;
Zandi, PP ;
Khachaturian, AS ;
Anthony, JC ;
Mayer, L .
NEUROLOGY, 2002, 58 (02) :209-218
[28]   Mild cognitive impairment - Clinical characterization and outcome [J].
Petersen, RC ;
Smith, GE ;
Waring, SC ;
Ivnik, RJ ;
Tangalos, EG ;
Kokmen, E .
ARCHIVES OF NEUROLOGY, 1999, 56 (03) :303-308
[29]   VASCULAR DEMENTIA - DIAGNOSTIC-CRITERIA FOR RESEARCH STUDIES - REPORT OF THE NINDS-AIREN INTERNATIONAL WORKSHOP [J].
ROMAN, GC ;
TATEMICHI, TK ;
ERKINJUNTTI, T ;
CUMMINGS, JL ;
MASDEU, JC ;
GARCIA, JH ;
AMADUCCI, L ;
ORGOGOZO, JM ;
BRUN, A ;
HOFMAN, A ;
MOODY, DM ;
OBRIEN, MD ;
YAMAGUCHI, T ;
GRAFMAN, J ;
DRAYER, BP ;
BENNETT, DA ;
FISHER, M ;
OGATA, J ;
KOKMEN, E ;
BERMEJO, F ;
WOLF, PA ;
GORELICK, PB ;
BICK, KL ;
PAJEAU, AK ;
BELL, MA ;
DECARLI, C ;
CULEBRAS, A ;
KORCZYN, AD ;
BOGOUSSLAVSKY, J ;
HARTMANN, A ;
SCHEINBERG, P .
NEUROLOGY, 1993, 43 (02) :250-260
[30]   Treatment of Alzheimer's disease: current status and new perspectives [J].
Scarpini, E ;
Scheltens, P ;
Feldman, H .
LANCET NEUROLOGY, 2003, 2 (09) :539-547